Imperfect gold standards for biomarker evaluation

Clinical Trials

Volumn 10, Issue 5, 2013, Pages 696-700

  Waikar, Sushrut S ^a   Betensky, Rebecca A ^b   Emerson, Sarah C ^b   Bonventre, Joseph V ^a,c  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; CREATININE; TROPONIN;

ACUTE KIDNEY FAILURE; BLOOD SAMPLING; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; DIAGNOSTIC ERROR; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DRUG EXPOSURE; GOLD STANDARD; HEART INFARCTION; HUMAN; KIDNEY FUNCTION; LABORATORY TEST; LONG TERM CARE; MORTALITY; NEPHROTOXICITY; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECEIVER OPERATING CHARACTERISTIC; RENAL REPLACEMENT THERAPY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

ACUTE KIDNEY INJURY; BIOLOGICAL MARKERS; CREATININE; FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; HUMANS; PREVALENCE; RENAL DIALYSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY;

EID: 84886930817     PISSN: 17407745     EISSN: 17407753     Source Type: Journal    
DOI: 10.1177/1740774513497540     Document Type: Conference Paper

References (14)

1. Buck AA, Gart JJ. Comparison of a screening test and a reference test in epidemiologic studies. I. Indices of agreement and their relation to prevalence. Am J Epidemiol. 1966 ; 83: 586-92
2. Staquet M, Rozencweig M, Lee YJ, Muggia FM. Methodology for the assessment of new dichotomous diagnostic tests. J Chronic Dis. 1981 ; 34: 599-610
3. Phelps CE, Hutson A. Estimating diagnostic test accuracy using a 'fuzzy gold standard'. Med Decis Making. 1995 ; 15: 44-57
4. Hui SL, Walter SD. Estimating the error rates of diagnostic tests. Biometrics. 1980 ; 36: 167-71
5. Walter SD, Irwig LM. Estimation of test error rates, disease prevalence and relative risk from misclassified data: A review. J Clin Epidemiol. 1988 ; 41: 923-37
6. Vacek PM. The effect of conditional dependence on the evaluation of diagnostic tests. Biometrics. 1985 ; 41: 959-68
7. Alonzo TA, Pepe MS. Using a combination of reference tests to assess the accuracy of a new diagnostic test. Stat Med. 1999 ; 18: 2987-3003
8. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996 ; 335: 1342-49
9. Hamm CW, Ravkilde J, Gerhardt W, et al. The prognostic value of serum troponin T in unstable angina. N Engl J Med. 1992 ; 327: 146-50
10. Wade R, Eddy R, Shows TB, Kedes L. cDNA sequence, tissue-specific expression, and chromosomal mapping of the human slow-twitch skeletal muscle isoform of troponin I. Genomics. 1990 ; 7: 346-57
11. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation. 2007 ; 116: 2634-53
12. Boldt J, Brenner T, Lang J, Kumle B, Isgro F. Kidney-specific proteins in elderly patients undergoing cardiac surgery with cardiopulmonary bypass. Anesth Analg. 2003 ; 97: 1582-89
13. Amur S, Frueh FW, Lesko LJ, Huang SM. Integration and use of biomarkers in drug development, regulation and clinical practice: A US regulatory perspective. Biomark Med. 2008 ; 2: 305-11
14. Waikar SS, Betensky RA, Emerson SC, Bonventre JV. Imperfect gold standards for kidney injury biomarker evaluation. J Am Soc Nephrol. 2012 ; 23 (1). 13-21